Universe Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of March 2025: 0.04x

Universe Pharmaceuticals Inc cash flow reinvestment rate. Universe Pharmaceuticals Inc (UPC) has a Cash Flow Reinvestment Rate of 0.04x as of March 2025, reinvesting $96.78K (capex $96.78K ) from operating cash flow of $2.56 Million. Explore debt repayment capacity of Universe Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.04x
(Capex + Investments) / Operating CF

Total Reinvested

$96.78K
Capex + Investments

Operating Cash Flow

$2.56 Million
USD

Capital Expenditures

$96.78K
USD

Cash Flow Reinvestment Rate of Universe Pharmaceuticals Inc (2018–2023)

Cash flow reinvestment rate of Universe Pharmaceuticals Inc from 2018 to 2023. Historical reinvestment intensity for Universe Pharmaceuticals Inc across 4 annual periods. Explore how much does Universe Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Universe Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2018–2023)

Universe Pharmaceuticals Inc cash flow reinvestment rate by year from 2018 to 2023. Year-by-year capital reinvestment analysis for Universe Pharmaceuticals Inc. For the full cash flow conversion analysis, see Universe Pharmaceuticals Inc (UPC) cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2023 0.08x $88.34K $1.12 Million $44.17K ▲ +365.6%
2020 0.02x $103.60K $6.12 Million $51.80K ▲ +29.8%
2019 0.01x $172.36K $13.20 Million $86.32K ▼ -80.0%
2018 0.07x $290.19K $4.46 Million $145.09K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow